Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ZNTL US Equity

Zentalis Pharmaceuticals, Inc.Health Care · Pharmaceutical Preparations · CIK 1725160 · FY ends Dec 31
$3.82
+0.14 (+3.80%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1913G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by WALTERS GROUPsec.gov ↗
2026-08-148-K 8.01Other eventssec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BARCLAYS PLCsec.gov ↗
2026-08-068-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-3013GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-30

Every row is a filed document, checked against its EDGAR index.